Differential regulation of SOCS‐1 signalling in B and T lymphocytes by hepatitis C virus core protein

Authors:

Abstract
Summary: Hepatitis C virus (HCV) infection is characterized by a strong propensity toward chronicity, autoimmune phenomena and lymphomagenesis, supporting a role for lymphocyte dysregulation during persistent viral infection. We have shown that HCV core protein inhibits T‐cell functions through interaction with a complement receptor, gC1qR. Here, we further report that B cells also express gC1qR that can be bound by HCV core protein. Importantly, using flow cytometry, we demonstrated differential regulation of B and T lymphocytes by the HCV core–gC1qR interaction, with down‐regulation of CD69 activation in T cells but up‐regulation of CD69 activation and cell proliferation in B cells. HCV core treatment led to decreased interferon‐γ production in CD8+ T cells but to increased immunoglobulin M and immunoglobulin G production as well as cell surface expression of costimulatory and chemokine receptors, including CD86 (B7‐2), CD154 (CD40L) and CD195 (CCR5), in CD20+ B cells. Finally, we showed down‐regulation of suppressor of cytokine signalling‐1 (SOCS‐1) using real‐time reverse transcription–polymerase chain reaction, accompanied by up‐regulation of signal transducer and activator of transcription‐1 (STAT1) phosphorylation in B cells in response to HCV core protein, with the opposite pattern observed in HCV core‐treated T cells. This study demonstrates differential regulation of B and T lymphocytes by HCV core and supports a mechanism by which lymphocyte dysregulation occurs in the course of persistent HCV infection.

This publication has 41 references indexed in Scilit: